Authors: Ke Dong Song, Peng Fei Wen, Tian Qing Liu, Li Li Jiang, Guan Yu Mei
Abstract: In this study, the surface modification and biocompatibility of the biologic chitosan
scaffold were investigated. The chitosan scaffold with excellent reticular structure was attained after
being purified, emulsionized, cross-linked, molded and freeze-dried step by step by using the native
materials, coming from such as lobster shell, crab shell etc.. After that, its surface modification was
operated with film coating by using gelatin. Then the bone marrow mesenchymal stem cells (BMSCs)
derived from New Zealand rabbits were used as the seed cells and were inoculated onto the modified
biologic chitosan scaffolds at 3×105 cells/ml to investigate the biocompatibility and bone conductive
efficiency of this kind of scaffold in static culture for one week. As a control, the cell suspensions with
same densities were inoculated onto the chitosan scaffold without being treated. During the whole
culture process, the cellular adherence and expansion were observed under inverted microscope.
After culture, the biological properties of the fabricated cell-scaffold tissues were detected by
scanning electron microscope (SEM) and HO/PI fluorescent double staining. The results showed that
the biologic chitosan scaffold treated with gelatin or rat-tail collagen promoted a higher adhesion and
proliferation of BMSCs in comparison to the untreated samples. Besides, the BMSCs within the
treated scaffold were more regular and well-distributed than those in untreated one. It is concluded
that this kind of surface modification can be used to change the physicochemical properties of
chitosan scaffold. The improved biologic chitosan scaffold is suitable to be an ideal biomedical
scaffold for tissue engineering.
654
Authors: Sandra Sánchez-Salcedo, Daniel Arcos, Maria Vallet-Regí
Abstract: The research on ceramic scaffolds for bone tissue engineering is, nowadays, one of the
newest and most attractive topics in the field of materials for biomedical applications.
These scaffolds are aimed to provide supporting or even enhance the reparative capacity of
body. Biphasic calcium phosphates (BCPs) and silicon doped BCP are very interesting
candidates to be used as materials for scaffolds fabrication in bone tissue engineering.
BCPs and silicon doped BCP consist of a mixture of hydroxyapatite (HA) and β-tricalcium
phosphate (β-TCP) or HA and α-tricalcium phosphate (α-TCP), respectively. For the
regenerative purposes BCPs show better performance than HA because of the higher
solubility of β-TCP compound, which facilitate the subsequent bone ingrowth in the
implant. On the other, silicon doped BCP involve silicon that substituted into the apaptite
crystal lattice for phosphorous with the subsequent charge imbalance. HA/α-TCP based
bioceramics exhibits an important improvement of the bioactive behaviour with respect to
non-substituted apatites. This work reviews the procedures to synthesise and fabricate
scaffolds based on HA/β-TCP and silicon stabilised HA/α-TCP. Special attraction has
been paid in the different synthesis methods and to the shaping of final scaffolds. By
knowing the scaffold features at the crystallinity and macrostuctural level, the
biocompatibility and clinical performance can be better understood, which will be also
considered in this review.
19
Authors: Min Zheng, Ding Fan, Xiu Kun Li, Qi Bin Liu, Wen Fei Li, Jian Bin Zhang
Abstract: Based on a high power CO2 laser beam passing by pyramid polygon mirror, the bioceramic
coatings of gradient composition were fabricated on titanium alloy substrate (Ti-6Al-4V). The relations
among laser processing parameters, microstructure and biocompatibility of the gradient bioceramic
coatings were investigated. The results indicated that the contents of rare earth oxide additions had an
immediate effect on the formation of bioactive phases. The gradient bioceramic coatings showed
favorable biocompatibility in vivo after they were implanted into canine femur for 45, 90, and 180 days,
respectively. The bioceramic coatings of Ca/P=1.4 and 0.6wt.% Y2O3 totally combined with new bones
merely implanted for 45 days. Furthermore, the MTT (Methyl Thiazolyl Tetrazolium) colorimetry results
of cell proliferation demonstrated that the cell growth distinctly increased on the gradient bioceramic
coatings by laser cladding compared with the un-treated titanium alloy substrate.
1203
Authors: Guy Daculsi, Eric Aguado, Pierre Corre, Xavier Bourges, Serge Baroth, Eric Goyenvalle
Abstract: Dedicated to Minimal Invasive Surgery MIS particularly in spine for vertebroplasty, the
surgeons and radiologists ask for improvement of radio opacity, to be sure of the injection site, and to
prevent injection in blood vessels. MBCP Gel® is an Injectible biomaterial non self hardening, the
biomaterials consists of BCP granules associated with a hydrosoluble polymer. These materials have
been shown to be perfectly biocompatible and potentially resorbable and, thanks to their initial
plasticity, they assume the shape of the bone defects very easily, eliminating the need to shape the
material to adjust to the implantation site. MBCP gels do not have mechanical properties like the
hydraulic bone cements. However bone cells are able to invade the spaces created by the
disappearance of the polymer carrier. Bone ingrowth takes place all around the granules at the expense
of the resorption of the BCP granules. In time, the mechanical property is increased due to the
presence of the newly formed bone. This study demonstrates an improvement of MBCP gel by freeze
drying and reconstitution using iodine solution or sterile water in a classical model of rabbit bone
defects.
1277
Authors: E.T. Uzumaki, C.S. Lambert, W.D. Belangero, Cecília A.C. Zavaglia
Abstract: A great number of studies have shown that diamond-like carbon (DLC) coatings could be
developed for orthopaedic implants, but few articles have been published about in vivo evaluation.
In this study, DLC coatings were deposited on titanium alloy (Ti-13Nb-13Zr) implants using the
plasma immersion implantation and deposition (PIII-D), and the in vivo biocompatibility of DLC
coatings was evaluated into both muscular tissue and femoral condyles of rats. Results indicate that
DLC coatings are biocompatible in vivo, and DLC-coated implants were observed directly bonding
to bone without any intervening soft tissue layer.
677
Authors: Anke Bernstein, Doreen Nöbel, Hermann O. Mayr, Renate Gildenhaar, Georg Berger, Ute Ploska, Joerg Brandt
Abstract: Bioactive ceramics such as hydroxypatite (HA) promote and enhance biological fixation.
There is still a discussion on the desired longevity of the coating. Stable coatings require an
optimum between resorption rate, flexural strength and adhesive strength of the coating.
Ceramic coatings containing fluorapatite (FA, Ca5(PO4)3F) and calcium zirconium phosphate
(CZP, CaZr4(PO4)6) promise lower resorption rates than conventional HA coatings in the biological
milieu. It is hoped that they can improve the long-term stability of implants by eliminating the
detrimental resorption of coating material. For the in vivo studies plasma sprayed coatings were
generated. The materials were implanted into the distal femur epiphysis of rabbits and investigated
after 2, 4, 6, 12, and 24 weeks postoperatively. Histological analysis was preformed on the areas
surrounding the implant. The amount of osseointegration was determined by using the
automatically image analysis. The bonding strengths were compared with HA coating and uncoated
titanium alloy. According to available data, there is inhibition of mineralization of bone at the
interface of calcium zirconium phosphate ceramics of the described composition.
641
Authors: K. Kida, Y. Horiguchi, Kazuya Oribe, H. Morisue, Morio Matsumoto, Y. Toyama, Mamoru Aizawa
Abstract: We have successfully developed novel “chelate-setting apatite cement” using
hydroxyapatite (HAp) particles surface-modified with inositol phosphate (IP6) . The HAp particles
surface-modified with IP6 were mixed with water (HAp/water ratio = 1.00/0.50[w/w]) to fabricate
apatite cements. We have examined the biocompatibility of the apatite cement using the culture
system of MC3T3-E1 cells and the rabbit model. The cell-culture test using MC3T3-E1 cells has
shown that the apatite cement has noncytotoxicity. This cement has been implanted into tibiae of
rabbits. When tissue response was examined histologically up to 24 weeks, new bone formation
was observed around the surface of the cement. The present work demonstrates that this apatite
cement is useful as a material for artificial bone grafting.
335
Authors: Daisuke Yamashita, Kenji Kanbara, Miho Machigashira, Motoharu Miyamoto, Hideo Sato, Yuichi Izumi, Seiji Ban
Abstract: The aim of this study was to evaluate the biocompatibility with the proliferation of
osteoblast-like cell (MC3T3-E1) on zirconia/alumina nanocomposite (NANOZR) in comparison to
yttria stabilized zirconia (3Y-TZP) and titanium (Ti). Cellular proliferations after 1-, 3-, 6-, and 9-day
incubation were calculated from the measurement of the MTT activities of the proliferated cell and
were analyzed by two-way ANOVA. Time-dependent proliferation of MC3T3-E1 in all the sample
was observed in all three materials with culture days. However, these were no significant differences
in the proliferation between three kinds of material, indicating all the materials have a similar-good
biocompatibility.
1099
Authors: M.M. Sovar, C. Ducu, D. Iordachescu, Ioana Demetrescu
Abstract: The present work is focused on the stability of bioactivated CoCr alloy in biological
environment (buffered saline solution (PBS), lactic acid, citric acid). The chemical and
electrochemical deposition was characterized by electrochemical methods (open circuit potential,
cyclic voltametry), scanning electronic microscope (SEM), x-ray diffractometer (XRD), inductively
coupled plasma/mass spectrometry (ICP/MS) and citotoxicity test. The results prove a good
electrochemical stability in all cases.
737
Authors: D. Ionita, E. Aldea, G. Stanciu, Ioana Demetrescu
Abstract: The aim of this paper was to find and establish the contact: biomaterial implant
(TiAlZr) - coated with biologically active molecules; and the correlation between surface
characteristics and their efficiency.
733